New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin...
Guardado en:
Autores principales: | Alberto J Lorenzatti, Peter P Toth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a811fc3ce3924d8caabd2cbb418db7ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Anandita Agarwala, et al.
Publicado: (2020) -
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
por: Ricardo Lopez Santi, et al.
Publicado: (2021) -
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021) -
Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021) -
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)